Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Atellica CH Enzymatic Creatinine_3 (ECre3)

K-Number: K212223 · 2021-11-24

Decision Date2021-11-24
Product CodeJFY
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Atellica CH Enzymatic Creatinine_3 (ECre3) is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2021-11-24 under approval number K212223. The device is classified under product code JFY. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Atellica CH Enzymatic Creatinine_3 (ECre3)?

Atellica CH Enzymatic Creatinine_3 (ECre3) is a medical device that received FDA 510(k) clearance on 2021-11-24. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K212223.

When was Atellica CH Enzymatic Creatinine_3 (ECre3) approved by the FDA?

Atellica CH Enzymatic Creatinine_3 (ECre3) received FDA 510(k) clearance on 2021-11-24, under approval number K212223.

What company makes Atellica CH Enzymatic Creatinine_3 (ECre3)?

Atellica CH Enzymatic Creatinine_3 (ECre3) is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for Atellica CH Enzymatic Creatinine_3 (ECre3)?

The FDA product code for Atellica CH Enzymatic Creatinine_3 (ECre3) is JFY.

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: JFY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.